You have 2 free disease views remaining today. Register for more view, it is 100% free →
autosomal dominant intellectual developmental disorder 51
Description
Autosomal dominant intellectual developmental disorder 51, also known as MRD51, is a rare genetic disorder that affects cognitive and adaptive functioning.
- The disorder is characterized by significantly below average general intellectual functioning, which is often accompanied by impairments in adaptive behavior [1][2].
- Individuals with MRD51 may experience delays in achieving motor or mental milestones, including motor skills, speech and language, and cognitive skills [4].
- The disorder is caused by mutations in the human homolog of a mouse gene associated with intellectual developmental disorders [3][5].
- Symptoms of MRD51 can include abnormality of head or neck, epicanthus, clubfoot, and other physical abnormalities [1].
It's worth noting that autosomal dominant intellectual developmental disorder 51 is a rare condition, and more research is needed to fully understand its effects on individuals and their families.
References: [1] - Search result 1: Clinical features [2] - Search result 2: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during ... [3] - Search result 3: A number sign (#) is used with this entry because of evidence that autosomal dominant intellectual developmental disorder-51 (MRD51) is caused by ... [4] - Search result 4: A delay in the achievement of motor or mental milestones in the domains of development of a child, including motor skills, speech and language, cognitive skills ... [5] - Search result 5: Mutations in human and/or mouse homologs are associated with this disease.
Additional Characteristics
- Abnormality of head or neck
- Clubfoot
- Epicanthus
- Significantly below average general intellectual functioning
- Impairments in adaptive behavior
- Delays in achieving motor or mental milestones (motor skills, speech and language, cognitive skills)
- Other physical abnormalities
Signs and Symptoms
Based on the available information, here are the signs and symptoms of autosomal dominant intellectual developmental disorder 51 (MRD51):
- Global Developmental Delay: MRD51 is characterized by global developmental delay, which means that affected individuals may experience delays in various aspects of development, such as cognitive, motor, and language skills [1].
- Intellectual Disability: Individuals with MRD51 may have intellectual disability or learning problems, ranging from mild to moderate in severity [2].
- Unique Personality Characteristics: People with MRD51 may exhibit unique personality characteristics, which can vary widely among affected individuals [3].
It's worth noting that the symptoms of MRD51 can be variable and may not be present in all affected individuals. Additionally, early diagnosis and intervention are crucial for managing the condition effectively.
References: [1] - Characterized by global developmental delay (DD) and variable degrees of intellectual disability (ID) [2] - This condition is characterized by mild to moderate intellectual disability or learning problems [3] - unique personality characteristics
Additional Symptoms
- Intellectual Disability
- Global Developmental Delay
- Unique Personality Characteristics
Diagnostic Tests
Autosomal dominant intellectual developmental disorders, also known as autosomal dominant intellectual disability (ADID), are a group of genetic conditions characterized by significantly below-average general intellectual functioning associated with impairments in adaptive behavior.
Diagnostic tests for ADID:
- Chromosomal microarray analysis: This test is used to identify copy number variations and deletions in the genome that may contribute to ADID. [1]
- Testing for fragile X syndrome: Fragile X syndrome is a genetic condition that can cause intellectual disability, and testing for it is often recommended as part of the diagnostic workup for ADID. [2]
- Karyotype analysis: This test examines the number and structure of chromosomes to identify any abnormalities that may be contributing to ADID. [3]
- Metabolic testing: Metabolic disorders can sometimes cause intellectual disability, so metabolic testing may be recommended in some cases. [4]
Other diagnostic approaches:
- Exome sequencing: Exome sequencing involves analyzing the protein-coding regions of the genome to identify genetic variants that may contribute to ADID. [5]
- Genetic counseling: Genetic counseling can help families understand the risks and implications of a diagnosis of ADID, as well as provide guidance on testing and management options.
It's worth noting that each individual with ADID is unique, and the diagnostic process will depend on the specific characteristics of the condition in question. A comprehensive evaluation by a multidisciplinary team of healthcare professionals, including geneticists, psychologists, and neurologists, is often necessary to make an accurate diagnosis and develop an effective treatment plan.
References:
[1] Context result 4: "Rationale for genetic testing"
[2] Context result 5: "Integrated disease information for Intellectual Developmental Disorder, Autosomal Dominant 33"
[3] Context result 7: "Autosomal dominant non-syndromic intellectual disability... Classification level: Subtype of disorder... Diagnostic tests (165)"
[4] Context result 4: "Rationale for genetic testing"
[5] Context result 9: "The intellectual disability exome involves analysis of exome sequencing data in a predefined yet regularly updated set of genes associated with non-syndromic..."
Additional Diagnostic Tests
- Metabolic testing
- Exome sequencing
- Karyotype analysis
- Chromosomal microarray analysis
- Testing for fragile X syndrome
Treatment
Autosomal dominant intellectual developmental disorder (ID) 51, also known as MRD51, is a rare genetic condition that affects brain development and can lead to intellectual disability.
Regarding drug treatment for MRD51, there are limited options available. However, some studies suggest that certain medications may help manage symptoms associated with this condition.
- Risperidone has been reported to be effective in treating disruptive, aggressive, and self-injurious behaviors in children with ID, including those with MRD51 [4].
- Other pharmacotherapeutic strategies under development for NDDs, such as MRD51, include the use of antipsychotics, mood stabilizers, and stimulants. However, more research is needed to determine their efficacy and safety in this specific population [1].
It's essential to note that each individual with MRD51 may respond differently to medication, and treatment should be tailored to the person's unique needs and symptoms.
References: [1] by DZ Wetmore · 2010 - This review discusses recent translational research based on animal models of genetic NDDs, including pharmacotherapeutic strategies under development. [4] by H El Mouhi · 2023 - Autosomal dominant intellectual development disorder-6 (MRD6) is a neurodevelopmental disorder caused by a genetic mutation in the grin2b gene.
Recommended Medications
- Antipsychotics
- Mood stabilizers
- Stimulants
- risperidone
- Risperidone
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for autosomal dominant intellectual developmental disorder (ID) involves a broad range of conditions that can present with similar symptoms.
- Fragile X syndrome: This is an X-linked disorder and the most common inherited cause of intellectual disability [1]. It is characterized by physical features such as long face, large ears, and macrocephaly.
- Cohen syndrome: A rare genetic disorder marked by multi-systemic involvement, causing developmental delays, intellectual disabilities, microcephaly, and other systemic features [9].
- Other autosomal dominant disorders: These include achondroplasia, some forms of amelogenesis imperfecta, and Marfan syndrome. Some individuals may carry the mutation without expressing the full spectrum of symptoms [3].
It's essential to consider these conditions in the differential diagnosis for autosomal dominant ID, as they can present with similar symptoms.
References: [1] Search result 7 [3] Search result 3 [9] Search result 9
Additional Differential Diagnoses
- Other autosomal dominant disorders
- Cohen syndrome
- fragile X syndrome
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2602
- owl#annotatedSource
- t353783
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080232
- core#notation
- DOID:0080232
- oboInOwl#hasDbXref
- MIM:617788
- IAO_0000115
- An autosomal dominant intellectual developmental disorder that has_material_basis_in heterozygous mutation in the KMT5B gene on chromosome 11q13.
- rdf-schema#label
- autosomal dominant intellectual developmental disorder 51
- oboInOwl#hasExactSynonym
- autosomal dominant mental retardation 51
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0060307
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.